Summit Therapeutics and AstraZeneca announced a partnership on July 4, 2025, to collaborate on lung cancer drug development.
3 reports, 0 independent
Updated Jul 4
Gone quiet
- Reports
- 3
- Developments
- 2
- Repetition
- 33%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Summit Therapeutics and AstraZeneca announced a partnership on July 4, 2025, to collaborate on lung cancer drug development.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Summit Therapeutics and AstraZeneca partnered on lung cancer drug development on July 4, 2025.
- AstraZeneca is actively marketing drugs in China, linked to lung cancer expertise in Shanghai.
Keep exploring
The entities involved
-
Summit Therapeutics
biopharmaceutical company
Nothing else this week.
-
AstraZeneca
British-Swedish pharmaceutical company
Related events
- American Cancer Society and AstraZeneca founded BCAM through a partnership between the two organizations.
- Eli Lilly and AstraZeneca are involved in drug development and market competition, with the FDA issuing approvals and legal actions involving both companies.
- Oracle Corporation and AstraZeneca announced a collaboration to accelerate clinical research.
- A partnership involving AstraZeneca and UNICEF addresses lung health and air pollution challenges in Thailand.
Coverage
Newest first; wire copies grouped- Unknown outlet
- Unknown outlet
- Unknown outlet